8th Circ. Won't Rehear Heart Defect Drug Competition Suit
The Eighth Circuit refused Tuesday to revisit a case in which the Federal Trade Commission claimed that drugmaker Lundbeck Inc. had unlawfully cornered the market on drugs used to treat heart...To view the full article, register now.
Already a subscriber? Click here to view full article